Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator

BACKGROUND AND PURPOSE: Intravenous recombinant tissue plasminogen activator (tPA) at a dose of 0.9 mg/kg body weight is associated with a high hemorrhagic transformation (HT) rate. Low-dose tPA (0.6 mg/kg) may have a lower hemorrhage rate but the mortality and disability rates at 90 days cannot be...

Descripción completa

Detalles Bibliográficos
Autores principales: Ong, Cheung-Ter, Wong, Yi-Sin, Wu, Chi-Shun, Su, Yu-Hsiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441661/
https://www.ncbi.nlm.nih.gov/pubmed/28572721
http://dx.doi.org/10.2147/DDDT.S133759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441661/
https://www.ncbi.nlm.nih.gov/pubmed/28572721
http://dx.doi.org/10.2147/DDDT.S133759

Ejemplares similares